Ekso Bionics Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Ekso Bionics Holdings has a total shareholder equity of $14.9M and total debt of $5.4M, which brings its debt-to-equity ratio to 36%. Its total assets and total liabilities are $29.2M and $14.3M respectively.
Key information
36.0%
Debt to equity ratio
US$5.36m
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.29m |
| Equity | US$14.87m |
| Total liabilities | US$14.34m |
| Total assets | US$29.21m |
Recent financial health updates
Is Ekso Bionics Holdings (NASDAQ:EKSO) A Risky Investment?
Jun 14
Health Check: How Prudently Does Ekso Bionics Holdings (NASDAQ:EKSO) Use Debt?
Feb 05Is Ekso Bionics Holdings (NASDAQ:EKSO) Weighed On By Its Debt Load?
Sep 22Recent updates
Take Care Before Jumping Onto Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Even Though It's 27% Cheaper
Nov 12Investors Give Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Shares A 26% Hiding
Aug 29Many Still Looking Away From Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)
Jul 13Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.00
May 02Market Still Lacking Some Conviction On Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)
Dec 20Sentiment Still Eluding Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)
Jun 19Ekso Bionics: Fragile Opportunity
Aug 24Is Ekso Bionics Holdings (NASDAQ:EKSO) A Risky Investment?
Jun 14Health Check: How Prudently Does Ekso Bionics Holdings (NASDAQ:EKSO) Use Debt?
Feb 05Ekso Bionics: Expecting More Of The Same
Jan 25Is Ekso Bionics Holdings (NASDAQ:EKSO) Weighed On By Its Debt Load?
Sep 22Financial Position Analysis
Short Term Liabilities: EKSO's short term assets ($21.1M) exceed its short term liabilities ($7.5M).
Long Term Liabilities: EKSO's short term assets ($21.1M) exceed its long term liabilities ($6.8M).
Debt to Equity History and Analysis
Debt Level: EKSO has more cash than its total debt.
Reducing Debt: EKSO's debt to equity ratio has reduced from 51.5% to 36% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EKSO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: EKSO has less than a year of cash runway if free cash flow continues to grow at historical rates of 9.1% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 11:42 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ekso Bionics Holdings, Inc. is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gregory Chodaczek | B. Riley Securities, Inc. |
| Craig Bijou | Cantor Fitzgerald & Co. |
| Gregory Chodaczek | CRT Capital Group |